Biomimetic Therapeutics (MM)
   
To register click here

Biomimetic Therapeutics Stock Price BMTI

Company Description : The Company develops and commercializes bio-active drug-device combination products used for bone and tissue regeneration for the healing of musculoskeletal injuries and diseases, including orthopedic, spine and sports injury applications. url: www.biomimetics.com

Name:
Biomimetic Therapeutics (MM)
Symbol:
NASDAQ:BMTI
Stock Market:
NASDAQ Stock Market
Type:
Common Stock
ISIN:
Description:
 Change (p)Change (%)CurBidAskHighLowOpenVolumeTimeA
-0.03-0.2213.4713.113.8613.5213.3313.58832816:22:52
To register Click hereRegister for free Biomimetic Therapeutics stock prices.

BioMimetic Therapeutics responds to FDA Regranex safety review : BioMimetic Therapeutics today responded to a US Food and Drug Administration (FDA) communication regarding its safety review of the drug Regranex, Johnson & Johnson's topical gel for the treatment of diabetic foot and...

Free Biomimetic Therapeutics Stock Charts

Biomimetic Therapeutics Historical Stock Chart
Biomimetic Therapeutics Historical Stock Chart
Biomimetic Therapeutics Monthly Stock Chart
Biomimetic Therapeutics Monthly Stock Chart
Biomimetic Therapeutics Intraday stock chart
Biomimetic Therapeutics Intraday stock chart

To register Click hereRegister for FREE streaming stock charts featuring overlays, annotations and more than 80 different studies including Level 2 Scope and Average True Range.

Get the Latest Biomimetic Therapeutics stock Price, quotes, trades and FREE Biomimetic Therapeutics stock charts, company information, annual reports, market news and announcements from ADVFN. We offer Intraday and historical stock prices for Biomimetic Therapeutics (BMTI) and other NASDAQ Stock Market listed companies as well as company financials, Level 2 Data and the latest investor information from our stock market Message Boards.

Biomimetic Therapeutics News

Latest Biomimetic Therapeutics News Headlines
DateTimeSource
Headline
03/28/20083:35AMTFNFBioMimetic Therapeutics responds to FDA Regranex safety review
03/12/20085:29PMTFNFBioMimetic Therapeutics 4Q net loss greater than Street view
11/14/200711:41AMTFNFCORRECT: BioMimetic 3Q loss widens, revenue and loss better than expected
11/13/20074:55PMTFNFBioMimetic 3Q loss widens, revenue and loss better than expected

Biomimetic Therapeutics Company Information

 Sector  Turnover (m)  Profit (m)  EPS - Basic  PE ratio  Mkt Cap (m)  NMS 
  0.00 0.00   0.0 N/A
To register Click hereRegister for FREE access to the latest Biomimetic Therapeutics company information and fundamental data for other USA Common Stock companies. More than 100 separate statistics including accounts payable / sales and inventory / sales.

Latest Biomimetic Therapeutics Stock Trade

 Type  Size  Price  Date  Tr.Time  Units 
  1071 13.47 07/23/2008 4:00PM USD


 



PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright1999-2008 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
ADDITIONAL SERVICES AVAILABLE FROM ADVFN
Upgrade - Click here for more information on ADVFN premium services Money Words - ADVFN Financial Glossary Investor Training ADVFN Financial Bookshop Online Training Academy
30 site:2us nasdaq bmti080724 03:35 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2005 | 2007 )